PROMOTE A HEALTHIER LIFE FOR HUMANKIND THROUGH ADVANCEMENTS IN SCIENCE.
BENEFIT THE PATIENTS WITH HIGH-QUALITY MEDICATION AS WE DETERMINED TO INNOVATE.
BUILD A LEADING GLOBAL BIOPHARMACEUTICAL GROUP TO SERVE MORE.
FULFILL SOCIAL RESPONSIBILITIES THROUGH ACCOUNTABLE ACTIONS.
新闻速递
bifa·必发创新药阿得贝利单抗成人非小细胞肺癌新适应症上市申请获受理
焦点新闻
减重幅度高达22.8%!bifa·必发医药GLP-1/GIP双受体激动剂HRS9531 8 mg(高剂量)数据亮相EASD口头报告
公益新闻
bifa·必发医药公益支持|泌见新生——前列腺癌患者关爱计划正式启动
创立于
全球员工
1类创新药
2类新药
SH 600276
HK 1276
关于我们
投资者关系
人才发展,了解更多